Search clinical trials for: Durvalumab in combination with tremelimumab
Total 463565 results
-
BayerRecruitingUnresectable Hepatocellular CarcinomaGreece, Brazil, China, Colombia, Italy, Korea, Republic of, Saudi Arabia, Spain, Taiwan, Thailand, United States, Argentina, France, Mexico, Turkey
-
AbbVieRecruiting
-
AstraZenecaRecruiting
-
AHS Cancer Control AlbertaNot yet recruitingPancreatic Cancer | Cholangiocarcinoma | Biliary Tract Cancer | Hepatocellular CancerCanada
-
AstraZenecaRecruitingHepatocellular CarcinomaSpain, Canada, Germany, Belgium, United States, France, Italy, Japan, China, Egypt, India, Russian Federation, Taiwan, Vietnam, Thailand, Saudi Arabia, Portugal, Korea, Republic of, Brazil, Malaysia, Mexico, Philippines, Puerto Rico
-
AstraZenecaRecruitingMuscle Invasive Bladder CancerNetherlands, United Kingdom, Korea, Republic of, Canada, Germany, Italy, Poland, Spain, Turkey, Vietnam, Argentina, Japan, France, Brazil, Taiwan, United States, Israel, Austria, Chile, Colombia, Greece, Hong Kong, Mexico, Portugal, Russian... and more
-
Institut für Klinische Krebsforschung IKF GmbH...Hannover Medical School; AstraZenecaRecruitingHCC | Hepatocellular Carcinoma Non-resectableGermany
-
Georgetown UniversityAstraZenecaRecruitingCarcinoma, Non-Small Cell LungUnited States
-
Yonsei UniversitySamsung Medical Center; AstraZeneca; Seoul National University Hospital; Korean... and other collaboratorsRecruitingPlatinum-resistant Recurrent Ovarian CancerKorea, Republic of
-
Prisma Health-UpstateAstraZeneca; MedImmune LLCRecruitingCancer | Rare DiseaseUnited States
-
AstraZenecaActive, not recruitingSmall Cell Lung Carcinoma Extensive DiseaseGermany, United States, Poland, Taiwan, Turkey, Italy, Korea, Republic of, Brazil, Czechia, Hungary, Japan, Russian Federation, China, Netherlands, Spain, Israel, Ukraine, Austria, France, Bulgaria, Romania, Argentina, Slovakia
-
MedImmune LLCActive, not recruitingHepatocellular CarcinomaUnited States, Italy, Spain, Taiwan, Korea, Republic of, China, Hong Kong, Japan, Singapore
-
AstraZenecaActive, not recruitingCarcinoma, Non-Small-Cell Lung | Small Cell Lung Carcinoma | Carcinoma, Squamous Cell of Head and NeckUnited States, Taiwan, Korea, Republic of, Japan, Spain
-
University of Alabama at BirminghamTerminatedCholangiocarcinomaUnited States
-
Seoul National University HospitalActive, not recruitingBiliary Tract NeoplasmsKorea, Republic of
-
Gustave Roussy, Cancer Campus, Grand ParisActive, not recruitingLung Cancer | Head and Neck Squamous Cell Carcinoma | Oesophageal CancerFrance
-
Ludwig Institute for Cancer ResearchAstraZenecaCompletedEsophageal CancerUnited Kingdom
-
Association Pour La Recherche des Thérapeutiques...Active, not recruitingInfiltrating Bladder Urothelial CarcinomaFrance
-
Abramson Cancer Center at Penn MedicineCompletedMelanoma | Breast Cancer | Pancreatic Cancer | Metastatic | Non Small Cell Lung Cancer (NSCLC)United States
-
AstraZenecaActive, not recruitingMetastatic Urothelial Cancer | Unresectable Locally Advanced Urothelial CancerUnited States, Italy, Spain, Canada, Hungary, Poland, Argentina, Thailand, Vietnam, Turkey, Korea, Republic of, Brazil, Czechia, India, Japan, Philippines, Russian Federation, China, Taiwan, Israel, Australia, Bulgaria
-
Dana-Farber Cancer InstituteAstraZenecaSuspendedMesotheliomaUnited States
-
Immunocore LtdAstraZenecaCompletedMalignant MelanomaUnited States
-
UNICANCERAstraZeneca; National Cancer Institute, France; Pierre Fabre LaboratoriesActive, not recruitingBreast Cancer | Head and Neck Cancer | Prostate Cancer | Cervix Cancer | Advanced Solid TumoursFrance
-
AstraZenecaCompletedPlatinum Refractory Extensive-Stage Small Cell Lung CarcinomaSpain, Poland, Hungary, Ukraine, Germany
-
AstraZenecaCompletedPancreatic Ductal Adenocarcinoma | Triple-negative Breast Cancer | Urothelial Bladder CancerUnited States, Belgium, Korea, Republic of, Poland, Netherlands
-
National Cancer Institute (NCI)CompletedColorectal Neoplasms | Colorectal Cancer | Colorectal Carcinoma | Colorectal Adenocarcinoma | Refractory CancerUnited States
-
Eli Lilly and CompanyAstraZenecaCompletedSolid TumorUnited States, Belgium, Israel, Czechia
-
AstraZenecaCompletedNon - Small Cell Lung Cancer NSCLCUnited States, France, Germany, Italy, United Kingdom, Belgium, Poland, Romania, Taiwan, Thailand, Canada, Korea, Republic of, Czechia, Hungary, Japan, Russian Federation, Hong Kong, Spain, Netherlands, Greece, Australia, Serbia, Bu... and more
-
University of NebraskaAstraZenecaTerminatedSmall Cell Lung CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedHepatocellular Carcinoma | Cholangiocarcinoma | Bile Duct Cancer | Biliary Tract Neoplasms | Liver CancerUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisWithdrawnMetastatic Colorectal Cancer | Triple Negative Breast Cancer | Esophageal Adenocarcinoma | Prostate Adenocarcinoma | Stomach Adenocarcinoma
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited States, Germany, Italy, United Kingdom, Canada, France, Korea, Republic of, Netherlands
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLCCompletedRenal Cell Carcinoma | Cervical Cancer | Breast Cancer | Colorectal Cancer | Ovarian CancerUnited States
-
Ludwig Institute for Cancer ResearchBoehringer Ingelheim; MedImmune LLC; PharmaJet, Inc.; CureVac; Cancer Research Institute...CompletedNSCLC | Metastatic Non-small Cell Lung CancerUnited States
-
AIO-Studien-gGmbHAstraZenecaWithdrawn
-
Northwestern UniversityNational Cancer Institute (NCI); AstraZeneca; MedImmune LLCCompletedMalignant Glioma | Recurrent GlioblastomaUnited States
-
European Organisation for Research and Treatment...WithdrawnSquamous Non-small Cell Lung Cancer | Non-Squamous Non-small Cell Lung Cancer
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...AstraZenecaTerminated
-
National Cancer Institute (NCI)CompletedPancreatic Neoplasms | Pancreatic Cancer | Pancreas Cancer | Cancer of Pancreas | Cancer of the PancreasUnited States
-
AstraZenecaCompletedRecurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHNUnited States, France, Italy, Spain, Belgium, Czechia, Romania, Taiwan, Korea, Republic of, Brazil, Hungary, Japan, Russian Federation, Australia, Germany, Israel, Serbia, Bulgaria, Ukraine, Argentina, Poland, Chile, Croatia, Georgia
-
AstraZenecaCompletedStomach Neoplasms | Small Cell Lung Carcinoma | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Triple Negative Breast Neoplasms | Esophageal Squamous Cell Carcinoma | Carcinoma, Pancreatic Ductal | Carcinoma, Squamous Cell of Head and Neck | Esophagogastric Junction NeoplasmsKorea, Republic of, Japan
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Australia
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Germany, Spain, Canada, France, Korea, Republic of, Israel, Netherlands, United Kingdom
-
AstraZenecaCompletedMelanoma | Breast Cancer | Colorectal Cancer | Pancreatic Adenocarcinoma | Lung Cancer | Head and Neck Carcinoma | Biliary Tract Cancer | Gastroesophageal CancerUnited States
-
MedImmune LLCCompletedNSCLC | Lung Cancer | Non-small Cell Lung CancerUnited States, France, Italy, Spain, Belgium, United Kingdom, Korea, Republic of, Australia, Taiwan
-
MedImmune LLCCompletedSelect Advanced Solid TumorsUnited States, France, Netherlands
-
MedImmune LLCCompletedDiffuse Large B-Cell LymphomaUnited States, France, United Kingdom, Ireland
-
AstraZenecaCompletedMetastatic Pancreatic Ductal AdenocarcinomaSpain, Canada, Korea, Republic of, Netherlands, United States, Germany
-
MedImmune LLCTerminatedAdvanced Solid Tumors | Aggressive B-cell LymphomasUnited States
-
Centre Leon BerardGroupe Français de Pneumo-CancérologieNot yet recruitingLarge Cell Neuroendocrine Carcinoma of the LungFrance